Novavax Inc (NVAX NASDAQ) stock market data APIs
$8.0734
-0.11(-1.4%)
as of September 15, 2025
Try our APIs with
free plan!
Novavax Inc Financial Data Overview
Price chart is built with
Anychart
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Prev. Close
8.0734
Open
7.9598
High
8.2034
Low
7.8078
52 wk Range
5.01-15.22
Market Cap
1 296 M
P/E Ratio
3.5946
Shares Outstanding
162 M
Revenue
1 079 M
EPS
0.62
Beta
2.684
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Novavax Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Novavax Inc data using free add-ons & libraries
Get Novavax Inc Fundamental Data
Novavax Inc Fundamental data includes:
- Net Revenue: 1 079 M
- EBITDA: 408 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-06
- EPS/Forecast: -0.06
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Novavax Inc News
New
Former Trump surgeon general says RFK Jr. must go
[House Hearing Considers How To Overcome Vaccine Hesitancy] Drew Angerer/Getty Images News Jerome Adams, who served as U.S. surgeon general during the first Trump administration, said that Robert F. ...
COVID-19 Vaccine Stocks Fall on Reports Linking Shots to Child Deaths
Shares of prominent COVID-19 vaccine makers Moderna (MRNA), BioNTech (BNTX), Pfizer (PFE), and Novavax (NVAX) fell on Friday following reports that the Trump administration is preparing to link COVID-...
Vaccine Stocks Fall Following Report of Plans to Link Covid Shot With Child Deaths
Shares of vaccine companies fell after a report that federal officials plan to link Covid-19 vaccines with child deaths. Pfizer shares declined 4%, Novavax shares fell 3.6%, Moderna shares were down 7...
COVID vaccine names take a hit after report of child deaths CDC presentation
[Move down arrow on blackboard background] Companies that manufacture authorized COVID-19 shots are down significantly following word [https://seekingalpha.com/news/4494450-hhs-officials-pin-25-child...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
